Semler Scientific (NASDAQ:SMLR) Posts Earnings Results, Beats Expectations By $0.35 EPS

Semler Scientific (NASDAQ:SMLR) announced its quarterly earnings results on Monday. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.35, Zacks reports. The business had revenue of $13.51 million for the quarter. Semler Scientific had a net margin of 25.62% and a return on equity of 21.17%.

Semler Scientific Stock Up 3.4 %

SMLR stock opened at $31.00 on Tuesday. The firm has a market capitalization of $216.69 million, a PE ratio of 14.69 and a beta of 0.92. Semler Scientific has a twelve month low of $20.88 and a twelve month high of $53.38. The stock’s 50 day moving average is $25.92 and its 200-day moving average is $28.63.

Insider Buying and Selling

In other Semler Scientific news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the firm’s stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $28.35, for a total transaction of $283,500.00. Following the transaction, the chief executive officer now directly owns 60,220 shares in the company, valued at approximately $1,707,237. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 30.20% of the stock is currently owned by corporate insiders.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.